Romain Sechaud
Professor
Biomedical Research
Novartis Institutes for Biomedical Research
Switzerland
Biography
Dr. Romain Sechaud is affiliated to Novartis Institutes for Biomedical Research, Novartis Institutes for Biomedical Research. Dr. Romain Sechaud is currently providing services as Professor. Dr. Romain Sechaud has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Romain Sechaud contributions have acclaimed recognition from honourable subject experts around the world. Dr. Romain Sechaud is actively associated with different societies and academies. Dr. Romain Sechaud academic career is decorated with several reputed awards and funding. Dr. Romain Sechaud research interests include Novartis Institutes for Biomedical Research. Dr. Romain Sechaud is affiliated to Novartis Institutes for Biomedical Research, Novartis Institutes for Biomedical Research. Dr. Romain Sechaud is currently providing services as Professor. Dr. Romain Sechaud has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Romain Sechaud contributions have acclaimed recognition from honourable subject experts around the world. Dr. Romain Sechaud is actively associated with different societies and academies. Dr. Romain Sechaud academic career is decorated with several reputed awards and funding. Dr. Romain Sechaud research interests include Novartis Institutes for Biomedical Research.
Research Interest
Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.
